BioSpace News Archive

Aegis Launches Infectious Disease Testing

Aegis Sciences Corporation has expanded its molecular testing capabilities to rapidly identify pathogens in the respiratory and urogenital health spaces.

October 11, 2021
·
2 min read
Biotech Beach

SeaSpine Announces Full Commercial Launch of The NorthStar OCT Posterior Cervical Fixation System

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of its NorthStar OCT Posterior Cervical Fixation System.

October 11, 2021
·
4 min read
Deals

Rejuveron leads EUR 15.7 million Series B investment in Rejuvenate Biomed to accelerate clinical development of its sarcopenia treatment for healthy aging

Rejuveron Life Sciences AG today announced that it will ultimately acquire a majority shareholding in Rejuvenate Biomed NV.

October 11, 2021
·
4 min read
BioForest

Parse Biosciences Extends RNA-Seq Kit Reach to Australia and New Zealand through Decode Sciences Agreement

Parse Biosciences today announced a partnership with Decode Science to provide Parse’s single-cell RNA-seq solution to the Australian and New Zealand markets.

October 11, 2021
·
3 min read
Drug Development

Sarepta Therapeutics’ SRP-9001 Shows Sustained Functional Improvements in Multiple Studies of Patients with Duchenne

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today shared new analyses and functional data from its SRP-9001 (rAAVrh74.MHCK7.micro-dystrophin) development program

October 11, 2021
·
12 min read
Drug Development

Therapeutic Solutions International Announces Initiation of JadiCell™ Manufacturing Program to Address Upcoming FDA Phase III Trial and Emergency Use Requests

Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced today initiation of pilot batch production of JadiCells, its umbilical cord stem cell product cleared by the FDA to enter Phase III clinical trials for COVID-19.

October 11, 2021
·
2 min read
Business

Octave Bioscience Announces Strategic Investment from the Merck Global Health Innovation Fund to Transform Disease Measurement and Care for Patients with Neurodegenerative Diseases

Octave Bioscience announced today that the Merck Global Health Innovation Fund (Merck GHIF) has made a strategic investment in Octave to further advance its industry-leading capabilities in neurodegenerative diseases.

October 11, 2021
·
4 min read
Bio NC

KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program

Eurofins DiscoverX Products, LLC (Eurofins DiscoverX), an industry leader in assays for drug discovery, development, and QC lot release, announced today the expansion of its Bioassay Certification Program through its certification of KBI Biopharma, Inc. (KBI), a JSR Life Sciences company.

October 11, 2021
·
4 min read
DEPRESSION PATENT FOR OROTATE APPROVED & GRANTED BY US PATENT OFFICE

Medlab Clinical LTD (ASX:MDC) is pleased to announce the Orotate patent, specifically to addressing depression in United States of America has been granted.

October 11, 2021
·
2 min read
Business

Terasaki Institute for Biomedical Innovation Signs Agreement with Qatar Foundation

The Terasaki Institute for Biomedical Innovation (TIBI) has recently signed an agreement with Qatar Foundation.

October 11, 2021
·
3 min read